INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Shareholders Of Pharmacyclics Inc. Of Commencement Of Class Action Investigation Concerning The Fairness Of The Sale Of The Company To AbbVie

The following statement is being issued by Levi & Korsinsky, LLP:

TO: ALL PERSONS OR ENTITIES WHO PURCHASED OR OTHERWISE ACQUIRED COMMON STOCK OF PHARMACYCLICS INC. PRIOR TO MARCH 4, 2015 AND CONTINUE TO HOLD SUCH SHARES.

YOU ARE HEREBY NOTIFIED that Levi & Korsinsky, LLP has commenced an investigation into the fairness of the sale of Pharmacyclics Inc. ("Pharmacyclics") (Nasdaq: PCYC) to AbbVie (NYSE: ABBV) for $261.25 per share in cash and stock. To learn more about the investigation and your rights, go to:

http://zlk.9nl.com/pharmacyclics-pcyc

There is no cost or obligation to you. Or contact Joseph E. Levi, Esq. either via email at jlevi@zlk.com or by telephone at (212) 363-7500, toll-free: (877) 363-5972.

Levi & Korsinsky is a national firm with offices in New York, New Jersey, Connecticut and Washington D.C. The firm's attorneys have extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities and shareholder lawsuits. For more information, please feel free to contact any of the attorneys listed below. Attorney advertising. Prior results do not guarantee similar outcomes.

Copyright Business Wire 2010

More from Press Releases

NFL Pushes for Regulation Following Supreme Court's Sports Gambling Ruling

NFL Pushes for Regulation Following Supreme Court's Sports Gambling Ruling

21st Century Fox Scoops Up Local News Stations

21st Century Fox Scoops Up Local News Stations

Walmart CEO: 'We Are Transforming Globally' With Flipkart

Walmart CEO: 'We Are Transforming Globally' With Flipkart

Three-Part FREE Webinar Series

Three-Part FREE Webinar Series

March 24 Full-Day Course Offering: Professional Approach to Trading SPX

March 24 Full-Day Course Offering: Professional Approach to Trading SPX